Robotic Intervention Framework for Children With Autism Spectrum Disorder to Enhance Social Engagement and Participation

NCT ID: NCT04879303

Last Updated: 2021-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-05-03

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will develop and test a Robotic Intervention Framework for Children with ASD in the real context. The first part of this study will focus on the identification and initial testing of core elements of effective robotic intervention programs to form a practice framework. Pat II will use a randomized control trial to test the efficacy of the robotic intervention programs that incorporated all elements of the framework. Part III will use a qualitative approach to examine the qualitative outcomes of the program with reference to the elements of the practice framework. With a framework that is built upon evidence and tested sufficiently, practice guidelines and intervention protocol will be delineated to ensure success of robotic intervention programs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autism Spectrum Disorder Social Engagement Robotic Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Robot-assisted social skill intervention

Social robotics will be used by the instructor to conduct the social skill training activities.

Group Type EXPERIMENTAL

Robot-assisted social skill intervention

Intervention Type BEHAVIORAL

Social robotics will be used by the instructor to teach social skills to the children with ASD for 12 weekly sessions.

Human-only instruction program on social skill training

The children will receive only the human-delivered social skill training.

Group Type ACTIVE_COMPARATOR

Human-only instruction programme on social skill training

Intervention Type BEHAVIORAL

The children will receive only the human-delivered training throughout the 12 sessions, with the content and sequence of activities the same as the robotic intervention group.

Control

There will be no intervention conducted during the tested period

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Robot-assisted social skill intervention

Social robotics will be used by the instructor to teach social skills to the children with ASD for 12 weekly sessions.

Intervention Type BEHAVIORAL

Human-only instruction programme on social skill training

The children will receive only the human-delivered training throughout the 12 sessions, with the content and sequence of activities the same as the robotic intervention group.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinical diagnosis of autism spectrum disorder
* aged between 5-11
* normal intelligence

Exclusion Criteria

* with self-injurious or aggressive behavior
* with hearing or visual impairment
Minimum Eligible Age

5 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Education University of Hong Kong

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eva Chung Yin-han

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva Yin-han Chung, PhD

Role: PRINCIPAL_INVESTIGATOR

The Education University of Hong Kong

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Education University of Hong Kong

Hong Kong, , Hong Kong

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eva Yin-Han Chung, PhD

Role: CONTACT

+852 29488233

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eva Yin-han Chung, PhD

Role: primary

+852 29488233

References

Explore related publications, articles, or registry entries linked to this study.

Chung EY, Kuen-Fung Sin K, Chow DH. Effectiveness of Robotic Intervention on Improving Social Development and Participation of Children with Autism Spectrum Disorder - A Randomised Controlled Trial. J Autism Dev Disord. 2025 Feb;55(2):449-456. doi: 10.1007/s10803-024-06236-2. Epub 2024 Jan 17.

Reference Type DERIVED
PMID: 38231380 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R1230

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.